Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Research of the Intermediate and Advanced Hepatoma Treated by Cinobufacin by Perfusion of Hepatic Artery Combining the Arterial Embolotherapy

NCT01236690 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT01236690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01236690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Research of the Intermediate and Advanced Hepatoma Treated by Cinobufacin by Perfusion of Hepatic Artery Combining the Arterial Embolotherapy
Lead sponsor
Changhai Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2010
Completion date
November 30, 2013
Enrollment
284 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cinobufacin injection, hepatoma